Dr. Brufsky Discusses Resistance to HER2-Targeted Therapies

(2:33)

What Differentiates SABCS from Other Breast Cancer Conferences?

(4:45)

Dr. Brufsky on Adjuvant Bisphosphonates for Patients with Breast Cancer

(30)

Dr. Brufsky on Challenges in Breast Cancer

(1:6)

Dr. Brufsky - EndoPredict Testimonial

(2:44)

Dr. Brufsky on Trastuzumab Biosimilars in Breast Cancer

(1:1econd)

Dr. Brufsky Discusses Future Research into Bisphosphonates

(39)

Treating Bone Mets with Adam Brufsky, MD, PhD

(56:5)

A Functional Equation Problem

(7:19)

Dr. Brufsky on the Ascertainment Bias of COVID-19

(2:14)

Adam Brufsky, MD: COVID-19 and Spike Protein Glycosylation

(12:2)

Replay of the Live Conversation with Dr. Barbara Natterson Horowitz

(1:5:46)

Gene Expression Analysis and DNA Microarray Assays

(8:19)

Immunotherapy for TNBC

(3:45)

Dr. Brufsky Advises Doctors on Bevacizumab for Breast Cancer

(1:16)

Adam Brufsky, MD, PhD, discusses results of MONARCH-2, PALOMA-1 trials

(4:30)

Adam Brufsky, MD: SARS-CoV-2 Attenuation?

(7:50)

HER2-low as a separate entity for defining HER2 BC and its prognostic and biological significance

(1:25)

Dr Brufsky on the Unique Design of the Allogeneic SV-BR-1-GM Vaccine in Metastatic Breast Cancer

(1:29)

Therapeutic Options in Metastatic Triple-Negative Breast Cancer

(3:25)

Dr. Brufsky on Challenges Facing Biosimilars in Breast Cancer

(1:7)

The Biggest Challenges in Metastatic Triple-Negative Breast Cancer

(10:40)

Dr. Brufsky on Choosing When to do a Multiparameter Genomic Assay

(2:20)

Dr. Brufsky on Genomic Assays for Breast Cancer

(1:30)

Adam Brufsky, MD, PhD, discusses the issue of resistance to HER2-targeted therapy

(2:)

Dr. Brufsky Discusses the tnAcity Trial

(1:31)

Dr. Brufsky Discusses Reasons to Use Biosimilars in Oncology

(54)

Dr Adam Brufsky: Choosing a Therapy for Breast Cancer Patients

(1:19)

Dr. Brufsky on the Disease-Free Survival of Aromatase Inhibitors for Breast Cancer

(1:4)

The Evolving Standard of Care in Metastatic Triple-Negative Breast Cancer

(9:30)